Shopping Cart
Remove All
Your shopping cart is currently empty
RA190 inhibits proteasome function by covalently binding to cysteine 88 of ubiquitin receptor RPN13.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $52 | In Stock | In Stock | |
| 5 mg | $117 | In Stock | In Stock | |
| 10 mg | $171 | In Stock | In Stock | |
| 25 mg | $258 | In Stock | In Stock | |
| 50 mg | $460 | - | In Stock | |
| 100 mg | $676 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $153 | In Stock | In Stock |
| Description | RA190 inhibits proteasome function by covalently binding to cysteine 88 of ubiquitin receptor RPN13. |
| Targets&IC50 | HeLa cells:0.15 μM |
| In vitro | Multiple myeloma (MM) lines, even those resistant to bortezomib, are sensitive to RA190 via endoplasmic reticulum stress-related apoptosis. RA190 stabilizes targets of human papillomavirus (HPV) E6 oncoprotein, and preferentially kills HPV-transformed cells. |
| In vivo | RA190 administration profoundly reduces growth of multiple myeloma and ovarian cancer xenografts, and oral RA190 treatment retards HPV16+ syngeneic mouse tumor growth, without impacting spontaneous HPV-specific CD8+ T cell responses. |
| Molecular Weight | 596.76 |
| Formula | C28H23Cl5N2O2 |
| Cas No. | 1617495-03-0 |
| Smiles | Cl.N[C@@H](Cc1ccccc1)C(=O)N1C\C(=C\c2ccc(Cl)c(Cl)c2)C(=O)\C(C1)=C/c1ccc(Cl)c(Cl)c1 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 95 mg/mL (159.19 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (5.53 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.